Ofra Kessler

3.8k total citations
48 papers, 3.1k citations indexed

About

Ofra Kessler is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cell Biology. According to data from OpenAlex, Ofra Kessler has authored 48 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 29 papers in Cellular and Molecular Neuroscience and 11 papers in Cell Biology. Recurrent topics in Ofra Kessler's work include Angiogenesis and VEGF in Cancer (30 papers), Axon Guidance and Neuronal Signaling (29 papers) and Hippo pathway signaling and YAP/TAZ (8 papers). Ofra Kessler is often cited by papers focused on Angiogenesis and VEGF in Cancer (30 papers), Axon Guidance and Neuronal Signaling (29 papers) and Hippo pathway signaling and YAP/TAZ (8 papers). Ofra Kessler collaborates with scholars based in Israel, United States and Germany. Ofra Kessler's co-authors include Gera Neufeld, Asya Varshavsky, Niva Shraga‐Heled, Lawrence A. Chasin, Boaz Kigel, Yael Herzog, Gal Akiri, Noga Guttmann‐Raviv, Edmond Sabo and Yelena Mumblat and has published in prestigious journals such as Journal of Biological Chemistry, Nature reviews. Cancer and Blood.

In The Last Decade

Ofra Kessler

48 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ofra Kessler Israel 31 2.2k 1.6k 567 541 371 48 3.1k
Dana M. Brantley‐Sieders United States 33 2.2k 1.0× 1.4k 0.9× 900 1.6× 916 1.7× 352 0.9× 49 3.2k
Hua Miao United States 9 2.0k 0.9× 869 0.6× 684 1.2× 393 0.7× 137 0.4× 11 2.6k
Akiyoshi Uemura Japan 29 2.1k 0.9× 572 0.4× 398 0.7× 461 0.9× 279 0.8× 70 3.5k
Joëlle Roche France 32 2.5k 1.1× 887 0.6× 752 1.3× 291 0.5× 119 0.3× 59 3.1k
Nikki Cheng United States 28 1.4k 0.6× 552 0.4× 1.2k 2.0× 324 0.6× 566 1.5× 43 2.5k
Wei Bin Fang United States 22 1.1k 0.5× 620 0.4× 693 1.2× 385 0.7× 376 1.0× 47 1.9k
Marie‐May Coissieux Switzerland 17 978 0.4× 571 0.4× 573 1.0× 231 0.4× 468 1.3× 22 1.8k
Dana M. Brantley United States 14 1.4k 0.6× 447 0.3× 796 1.4× 278 0.5× 218 0.6× 14 2.0k
John P. O’Bryan United States 35 2.3k 1.0× 372 0.2× 708 1.2× 968 1.8× 1.0k 2.8× 77 3.9k
Géraldine Siegfried France 23 1.2k 0.5× 251 0.2× 633 1.1× 429 0.8× 210 0.6× 45 2.3k

Countries citing papers authored by Ofra Kessler

Since Specialization
Citations

This map shows the geographic impact of Ofra Kessler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofra Kessler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofra Kessler more than expected).

Fields of papers citing papers by Ofra Kessler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofra Kessler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofra Kessler. The network helps show where Ofra Kessler may publish in the future.

Co-authorship network of co-authors of Ofra Kessler

This figure shows the co-authorship network connecting the top 25 collaborators of Ofra Kessler. A scholar is included among the top collaborators of Ofra Kessler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofra Kessler. Ofra Kessler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sabag, Adi D., et al.. (2024). Soluble CD72, is a T-cell activator probably via binding to CD6 in homeostasis and autoimmunity. Frontiers in Immunology. 15. 1367120–1367120. 3 indexed citations
2.
Toledano, Shira, et al.. (2023). Plexin-A2 enables the proliferation and the development of tumors from glioblastoma derived cells. Cell Death and Disease. 14(1). 41–41. 7 indexed citations
3.
Sabag, Adi D., et al.. (2022). CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus. Journal of Autoimmunity. 134. 102960–102960. 7 indexed citations
4.
Sabag, Adi D., Jacob Bejar, Shira Toledano, et al.. (2019). Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma. Frontiers in Immunology. 10. 550–550. 26 indexed citations
5.
Toledano, Shira, Huayi Lü, Boaz Kigel, et al.. (2016). A SEMA3E mutant resistant to cleavage by furins (UNCL-SEMA3E) inhibits choroidal neovascularization. Experimental Eye Research. 153. 186–194. 6 indexed citations
6.
Toledano, Shira, Huayi Lü, Keren Ziv, et al.. (2016). A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization. PLoS ONE. 11(12). e0168122–e0168122. 8 indexed citations
7.
Neufeld, Gera, et al.. (2016). The role of the semaphorins in cancer. Cell Adhesion & Migration. 10(6). 652–674. 82 indexed citations
8.
Mumblat, Yelena, Ofra Kessler, Neta Ilan, & Gera Neufeld. (2015). Full-Length Semaphorin-3C Is an Inhibitor of Tumor Lymphangiogenesis and Metastasis. Cancer Research. 75(11). 2177–2186. 60 indexed citations
9.
Sabag, Adi D., Yelena Mumblat, Marius Ueffing, et al.. (2014). The role of the plexin-A2 receptor in semaphorin-3A and semaphorin-3B signal transduction. Journal of Cell Science. 127(Pt 24). 5240–52. 33 indexed citations
10.
Vadasz, Zahava, Tharwat Haj, Itzhak Rosner, et al.. (2012). Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus. Arthritis Research & Therapy. 14(3). R146–R146. 61 indexed citations
11.
Casazza, Andrea, Boaz Kigel, Federica Maione, et al.. (2012). Tumour growth inhibition and anti‐metastatic activity of a mutated furin‐resistant Semaphorin 3E isoform. EMBO Molecular Medicine. 4(3). 234–250. 76 indexed citations
12.
Lugassy, Jennie, et al.. (2011). The Enzymatic Activity of Lysyl Oxidas-like-2 (LOXL2) Is Not Required for LOXL2-induced Inhibition of Keratinocyte Differentiation. Journal of Biological Chemistry. 287(5). 3541–3549. 42 indexed citations
13.
Kigel, Boaz, Asya Varshavsky, Ofra Kessler, & Gera Neufeld. (2008). Successful Inhibition of Tumor Development by Specific Class-3 Semaphorins Is Associated with Expression of Appropriate Semaphorin Receptors by Tumor Cells. PLoS ONE. 3(9). e3287–e3287. 109 indexed citations
14.
Neufeld, Gera, et al.. (2007). Semaphorin Signaling in Vascular and Tumor Biology. Advances in experimental medicine and biology. 600. 118–131. 43 indexed citations
15.
Guttmann‐Raviv, Noga, et al.. (2007). Semaphorin-3A and Semaphorin-3F Work Together to Repel Endothelial Cells and to Inhibit Their Survival by Induction of Apoptosis. Journal of Biological Chemistry. 282(36). 26294–26305. 185 indexed citations
16.
Guttmann‐Raviv, Noga, et al.. (2005). The neuropilins and their role in tumorigenesis and tumor progression. Cancer Letters. 231(1). 1–11. 119 indexed citations
17.
Vadasz, Zehava, Ofra Kessler, Gal Akiri, et al.. (2005). Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2. Journal of Hepatology. 43(3). 499–507. 150 indexed citations
18.
Barnea, Eilon, Ilan Beer, R. Patoka, et al.. (2002). Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens. European Journal of Immunology. 32(1). 213–222. 73 indexed citations
19.
Neufeld, Gera, Ofra Kessler, & Yael Herzog. (2002). The Interaction of Neuropilin-1 and Neuropilin-2 with Tyrosine-Kinase Receptors for VEGF. Advances in experimental medicine and biology. 515. 81–90. 136 indexed citations
20.
Kessler, Ofra & Abraham Berman. (1985). Matrices with a transitive graph and inverse M-matrices. Linear Algebra and its Applications. 71. 175–185. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dana M. Brantley‐Sieders Breakdown of academic impact, for papers by Hua Miao Breakdown of academic impact, for papers by Akiyoshi Uemura Breakdown of academic impact, for papers by Joëlle Roche Breakdown of academic impact, for papers by Nikki Cheng Breakdown of academic impact, for papers by Wei Bin Fang Breakdown of academic impact, for papers by Marie‐May Coissieux Breakdown of academic impact, for papers by Dana M. Brantley Breakdown of academic impact, for papers by John P. O’Bryan Breakdown of academic impact, for papers by Géraldine Siegfried
Rankless by CCL
2026